Comparative effectiveness of atorvastatin monotherapy vs. atorvastatin plus bempedoic acid combination in patients with coronary artery disease: a multicenter observational study
Polski Merkuriusz Lekarski · 01.04.2026 · 54 (2) · 190
DOI: 10.36740/merkur202602114 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Polski Merkuriusz Lekarski, online erschienen am 01.04.2026. Verfasst von Laith Rhabneh und 6 weiteren Autor:innen. Beteiligte Einrichtung: INTERNAL MEDICINE DEPARTMENT, HACKENSACK MERIDIAN OCEAN UNIVERSITY MEDICAL CENTER, BRICK TOWNSHIP, UNITED STATES. Hauptthemen laut MEDLINE: Atorvastatin, Coronary Artery Disease, Dicarboxylic Acids, Fatty Acids. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Aim
To evaluate the impact of adding bempedoic acid to atorvastatin therapy on cardiovascular outcomes, including major adverse cardiovascular events (MACE), cardiac arrest, all-cause hospitalization, and myopathy, in patients with established coronary artery disease Materials and methods: We conducted a retrospective cohort study using the TriNetX global health research network. Patients with established CAD were categorized based on their antilipemic therapy into two cohorts: atorvastatin monotherapy and atorvastatin plus bempedoic acid. Propensity score matching was employed to balance baseline characteristics between the cohorts. The primary outcome was the occurrence of MACE, while secondary outcomes included cardiac arrest events, all-cause hospitalization, and incidence of myopathy.
Results
After matching, 6,549 patients were included in each cohort. MACE occurred more frequently in the atorvastatin group (5.7%) compared to the combination therapy group (3.2%), with a hazard ratio of 1.606 (95% CI: 1.302-1.980, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INTERNAL MEDICINE DEPARTMENT, HACKENSACK MERIDIAN OCEAN UNIVERSITY MEDICAL CENTER, BRICK TOWNSHIP, UNITED STATES.
- DEPARTMENT OF INTERNAL MEDICINE, NORTHWEST HEALTH - LA PORTE, LA PORTE, UNITED STATES.
- DEPARTMENT OF INTERNAL MEDICINE, UNIVERSITY OF MARYLAND MIDTOWN CAMPUS, BALTIMORE, UNITED STATES.
- DEPARTMENT OF INTERNAL MEDICINE, ASCENSION SAINT AGNES HOSPITAL, BALTIMORE, UNITED STATES.
- INTERNAL MEDICINE DEPARTMENT, JORDAN UNIVERSITY HOSPITAL, AMMAN, JORDAN.
- HEALTHCARE SERVICES, JORDAN MINISTRY OF HEALTH, AMMAN, JORDAN.
Zitieren
APA
Rhabneh, L., Ababneh, R., Alnaser, I., Aloqaily, M., Alfarrajin, I., Albadawi, I., & Amawi, A. (2026). Comparative effectiveness of atorvastatin monotherapy vs. atorvastatin plus bempedoic acid combination in patients with coronary artery disease: a multicenter observational study. Polski Merkuriusz Lekarski, 54(2), 190. https://doi.org/10.36740/merkur202602114
Vancouver
Rhabneh L, Ababneh R, Alnaser I, Aloqaily M, Alfarrajin I, Albadawi I, et al. Comparative effectiveness of atorvastatin monotherapy vs. atorvastatin plus bempedoic acid combination in patients with coronary artery disease: a multicenter observational study. Polski Merkuriusz Lekarski. 2026;54(2):190. doi:10.36740/merkur202602114
BibTeX
@article{Rhabneh2026,
author = {Rhabneh, Laith and Ababneh, Ra'ed and Alnaser, Ibrahim and Aloqaily, Mohammed and Alfarrajin, Ibrahim and Albadawi, Ismail and Amawi, Abdalslam},
title = {Comparative effectiveness of atorvastatin monotherapy vs. atorvastatin plus bempedoic acid combination in patients with coronary artery disease: a multicenter observational study},
journal = {Polski Merkuriusz Lekarski},
year = {2026},
volume = {54},
number = {2},
pages = {190},
doi = {10.36740/merkur202602114}
}
EUVIMED